Thermo-Tunable Pores and Antibiotic Gating Properties of Bovine Skin Gelatin Gels 

Thermo-Tunable Pores and Antibiotic Gating Properties of Bovine Skin Gelatin Gels 

Publicity to a Manuka Honey Wound Gel Is Related With Adjustments in Bacterial Virulence and Antimicrobial Susceptibility

Using manuka honey for the topical therapy of wounds has elevated worldwide owing to its broad spectrum of exercise in the direction of micro organism in each planktonic and biofilm development modes. Regardless of this, the potential penalties of bacterial publicity to manuka honey, as could happen through the therapy of persistent wounds, will not be absolutely understood.

Right here, we describe adjustments in antimicrobial susceptibility and virulence in a panel of micro organism, together with wound isolates, following repeated publicity (ten passages) to sub-inhibitory concentrations of a manuka honey primarily based wound gel. Adjustments in antibiotic sensitivity above 4-fold had been predominantly associated to elevated vancomycin sensitivity within the staphylococci.

Curiously, Staphylococcus epidermidis displayed phenotypic resistance to erythromycin following passaging, with susceptibility profiles returning to baseline within the absence of additional honey publicity. Adjustments in susceptibility to the examined wound gel had been average (≤ 1-fold) when in comparison with the respective guardian pressure.

In sessile communities, elevated biofilm eradication concentrations over 4-fold occurred in a wound isolate of Pseudomonas aeruginosa (WIBG 2.2) as evidenced by a 7-fold discount in gentamicin sensitivity following passaging. On the subject of pathogenesis, 4/eight micro organism exhibited enhanced virulence following honey wound gel publicity. Within the pseudomonads and S. epidermidis, this occurred together with elevated haemolysis and biofilm formation, while P. aeruginosa additionally exhibited elevated pyocyanin manufacturing.

The place virulence attenuation was famous in a passaged wound isolate of S. aureus (WIBG 1.6), this was concomitant to delayed coagulation and decreased haemolytic potential. Total, passaging within the presence of a manuka honey wound gel led to adjustments in antimicrobial sensitivity and virulence that various between take a look at micro organism.

soveinc
soveinc

Mouse Gelsolin (GS) ELISA Kit

RD-GS-Mu-48Tests 48 Tests
EUR 586.8

Mouse Gelsolin (GS) ELISA Kit

RD-GS-Mu-96Tests 96 Tests
EUR 812.4

Gelsolin (GS) Antibody

20-abx132379
  • EUR 360.00
  • EUR 861.60
  • EUR 460.80
  • EUR 184.80
  • EUR 292.80
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Gelsolin (GS) Antibody

20-abx100097
  • EUR 427.20
  • EUR 159.60
  • EUR 1195.20
  • EUR 594.00
  • EUR 360.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Gelsolin (GS) Antibody

20-abx100098
  • EUR 427.20
  • EUR 159.60
  • EUR 1195.20
  • EUR 594.00
  • EUR 360.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Gelsolin (GS) Antibody

20-abx100099
  • EUR 510.00
  • EUR 159.60
  • EUR 1412.40
  • EUR 693.60
  • EUR 393.60
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Gelsolin (GS) Antibody

20-abx100100
  • EUR 543.60
  • EUR 159.60
  • EUR 1545.60
  • EUR 744.00
  • EUR 410.40
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Gelsolin (GS) Antibody

20-abx131113
  • EUR 427.20
  • EUR 159.60
  • EUR 1195.20
  • EUR 594.00
  • EUR 360.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Gelsolin (GS) Antibody

20-abx128513
  • EUR 427.20
  • EUR 159.60
  • EUR 1195.20
  • EUR 594.00
  • EUR 360.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Gelsolin (GS) Antibody

20-abx129516
  • EUR 493.20
  • EUR 159.60
  • EUR 1362.00
  • EUR 661.20
  • EUR 376.80
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Gelsolin (GS) Antibody

20-abx176577
  • EUR 477.60
  • EUR 159.60
  • EUR 1296.00
  • EUR 644.40
  • EUR 376.80
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Gelsolin (GS) Antibody

20-abx176578
  • EUR 1362.00
  • EUR 661.20
  • 1 mg
  • 200 ug

Gelsolin (GS) Antibody

20-abx176579
  • EUR 1646.40
  • EUR 777.60
  • 1 mg
  • 200 ug

Gelsolin (GS) Antibody Pair

20-abx370115
  • EUR 1713.60
  • EUR 1111.20
  • 10 × 96 tests
  • 5 × 96 tests

Gelsolin (GS) Antibody Pair

20-abx370757
  • EUR 2180.40
  • EUR 1395.60
  • 10 × 96 tests
  • 5 × 96 tests

Gelsolin (GS) Antibody Pair

20-abx370810
  • EUR 1963.20
  • EUR 1262.40
  • 10 × 96 tests
  • 5 × 96 tests

Gelsolin (GS) Antibody (FITC)

20-abx274147
  • EUR 610.80
  • EUR 309.60
  • EUR 1830.00
  • EUR 844.80
  • EUR 493.20
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Gelsolin (GS) Antibody (Biotin)

20-abx273100
  • EUR 577.20
  • EUR 292.80
  • EUR 1696.80
  • EUR 794.40
  • EUR 427.20
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Gelsolin (GS) Antibody (Biotin)

20-abx271800
  • EUR 477.60
  • EUR 276.00
  • EUR 1296.00
  • EUR 644.40
  • EUR 376.80
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Recombinant Gelsolin (GS)

4-RPA372Bo01
  • EUR 625.34
  • EUR 290.40
  • EUR 2015.04
  • EUR 751.68
  • EUR 1383.36
  • EUR 494.40
  • EUR 4857.60
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Bovine Gelsolin expressed in: E.coli

Recombinant Gelsolin (GS)

4-RPA372Hu01
  • EUR 582.34
  • EUR 279.60
  • EUR 1853.76
  • EUR 697.92
  • EUR 1275.84
  • EUR 465.60
  • EUR 4454.40
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Human Gelsolin expressed in: E.coli

Recombinant Gelsolin (GS)

4-RPA372Hu02
  • EUR 582.34
  • EUR 279.60
  • EUR 1853.76
  • EUR 697.92
  • EUR 1275.84
  • EUR 465.60
  • EUR 4454.40
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Human Gelsolin expressed in: E.coli

Recombinant Gelsolin (GS)

4-RPA372Hu03
  • EUR 582.34
  • EUR 279.60
  • EUR 1853.76
  • EUR 697.92
  • EUR 1275.84
  • EUR 465.60
  • EUR 4454.40
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Human Gelsolin expressed in: E.coli

Recombinant Gelsolin (GS)

4-RPA372Hu04
  • EUR 582.34
  • EUR 279.60
  • EUR 1853.76
  • EUR 697.92
  • EUR 1275.84
  • EUR 465.60
  • EUR 4454.40
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Human Gelsolin expressed in: E.coli

Recombinant Gelsolin (GS)

4-RPA372Mu01
  • EUR 603.84
  • EUR 285.60
  • EUR 1934.40
  • EUR 724.80
  • EUR 1329.60
  • EUR 480.00
  • EUR 4656.00
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Mouse Gelsolin expressed in: E.coli

Recombinant Gelsolin (GS)

4-RPA372Ra01
  • EUR 550.08
  • EUR 271.20
  • EUR 1732.80
  • EUR 657.60
  • EUR 1195.20
  • EUR 444.00
  • EUR 4152.00
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Rat Gelsolin expressed in: E.coli

Anti-Gelsolin Antibody (monoclonal, GS-2C4)

MA1044 100ug/vial
EUR 400.8

Gelsolin (GS) Monoclonal Antibody (Bovine)

4-MAA372Bo21
  • EUR 301.20
  • EUR 3091.20
  • EUR 768.00
  • EUR 379.20
  • EUR 258.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Mouse monoclonal antibody against Bovine Gelsolin (GS)

Gelsolin (GS) Monoclonal Antibody (Human)

4-MAA372Hu22
  • EUR 271.20
  • EUR 2616.00
  • EUR 660.00
  • EUR 336.00
  • EUR 246.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Mouse monoclonal antibody against Human Gelsolin (GS)

Gelsolin (GS) Polyclonal Antibody (Bovine)

4-PAA372Bo01
  • EUR 310.80
  • EUR 3232.80
  • EUR 800.40
  • EUR 391.20
  • EUR 261.60
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Bovine Gelsolin (GS)

Gelsolin (GS) Polyclonal Antibody (Human)

4-PAA372Hu01
  • EUR 260.40
  • EUR 2457.60
  • EUR 624.00
  • EUR 321.60
  • EUR 241.20
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Gelsolin (GS)

Gelsolin (GS) Polyclonal Antibody (Human)

4-PAA372Hu02
  • EUR 260.40
  • EUR 2457.60
  • EUR 624.00
  • EUR 321.60
  • EUR 241.20
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Gelsolin (GS)

Gelsolin (GS) Polyclonal Antibody (Human)

4-PAA372Hu03
  • EUR 260.40
  • EUR 2457.60
  • EUR 624.00
  • EUR 321.60
  • EUR 241.20
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Gelsolin (GS)

Gelsolin (GS) Polyclonal Antibody (Human)

4-PAA372Hu04
  • EUR 260.40
  • EUR 2457.60
  • EUR 624.00
  • EUR 321.60
  • EUR 241.20
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Gelsolin (GS)

Gelsolin (GS) Polyclonal Antibody (Rat)

4-PAA372Ra01
  • EUR 291.60
  • EUR 2948.40
  • EUR 735.60
  • EUR 366.00
  • EUR 254.40
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Rat Gelsolin (GS)

Mouse Gelsolin (GS) Protein

20-abx167397
  • EUR 844.80
  • EUR 343.20
  • EUR 2598.00
  • EUR 994.80
  • EUR 594.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Human Gelsolin (GS) Protein

20-abx168637
  • EUR 811.20
  • EUR 343.20
  • EUR 2498.40
  • EUR 961.20
  • EUR 577.20
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Human Gelsolin (GS) Protein

20-abx166832
  • EUR 811.20
  • EUR 343.20
  • EUR 2498.40
  • EUR 961.20
  • EUR 577.20
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Human Gelsolin (GS) Protein

20-abx066765
  • EUR 811.20
  • EUR 343.20
  • EUR 2498.40
  • EUR 961.20
  • EUR 577.20
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Rat Gelsolin (GS) Protein

20-abx066766
  • EUR 777.60
  • EUR 326.40
  • EUR 2331.60
  • EUR 910.80
  • EUR 560.40
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Cow Gelsolin (GS) Protein

20-abx066767
  • EUR 878.40
  • EUR 343.20
  • EUR 2715.60
  • EUR 1045.20
  • EUR 627.60
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Human Gelsolin (GS) Protein

20-abx066768
  • EUR 811.20
  • EUR 343.20
  • EUR 2498.40
  • EUR 961.20
  • EUR 577.20
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Human Gelsolin (GS) Protein

20-abx653524
  • EUR 693.60
  • EUR 309.60
  • EUR 2064.00
  • EUR 828.00
  • EUR 510.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Monkey Gelsolin (GS) Protein

20-abx653525
  • EUR 777.60
  • EUR 326.40
  • EUR 2397.60
  • EUR 927.60
  • EUR 560.40
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

OVA Conjugated Gelsolin (GS)

4-CPA372Hu21
  • EUR 464.06
  • EUR 247.20
  • EUR 1410.24
  • EUR 550.08
  • EUR 980.16
  • EUR 386.40
  • EUR 3345.60
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Human Gelsolin expressed in: Protein conjugation

Gelsolin (GS) Monoclonal Antibody (Bovine), APC

4-MAA372Bo21-APC
  • EUR 421.20
  • EUR 4038.00
  • EUR 1122.00
  • EUR 538.80
  • EUR 266.40
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Mouse monoclonal antibody against Bovine Gelsolin (GS). This antibody is labeled with APC.

Gelsolin (GS) Monoclonal Antibody (Bovine), Biotinylated

4-MAA372Bo21-Biotin
  • EUR 379.20
  • EUR 3031.20
  • EUR 892.80
  • EUR 464.40
  • EUR 265.20
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Mouse monoclonal antibody against Bovine Gelsolin (GS). This antibody is labeled with Biotin.

Gelsolin (GS) Monoclonal Antibody (Bovine), Cy3

4-MAA372Bo21-Cy3
  • EUR 512.40
  • EUR 5334.00
  • EUR 1446.00
  • EUR 668.40
  • EUR 304.80
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Mouse monoclonal antibody against Bovine Gelsolin (GS). This antibody is labeled with Cy3.

Gelsolin (GS) Monoclonal Antibody (Bovine), FITC

4-MAA372Bo21-FITC
  • EUR 361.20
  • EUR 3254.40
  • EUR 921.60
  • EUR 454.80
  • EUR 236.40
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Mouse monoclonal antibody against Bovine Gelsolin (GS). This antibody is labeled with FITC.

Gelsolin (GS) Monoclonal Antibody (Bovine), HRP

4-MAA372Bo21-HRP
  • EUR 385.20
  • EUR 3519.60
  • EUR 992.40
  • EUR 486.00
  • EUR 250.80
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Mouse monoclonal antibody against Bovine Gelsolin (GS). This antibody is labeled with HRP.

Gelsolin (GS) Monoclonal Antibody (Bovine), PE

4-MAA372Bo21-PE
  • EUR 361.20
  • EUR 3254.40
  • EUR 921.60
  • EUR 454.80
  • EUR 236.40
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Mouse monoclonal antibody against Bovine Gelsolin (GS). This antibody is labeled with PE.

Gelsolin (GS) Monoclonal Antibody (Human), APC

4-MAA372Hu22-APC
  • EUR 376.80
  • EUR 3390.00
  • EUR 960.00
  • EUR 474.00
  • EUR 247.20
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Mouse monoclonal antibody against Human Gelsolin (GS). This antibody is labeled with APC.

Gelsolin (GS) Monoclonal Antibody (Human), Biotinylated

4-MAA372Hu22-Biotin
  • EUR 345.60
  • EUR 2556.00
  • EUR 774.00
  • EUR 417.60
  • EUR 250.80
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Mouse monoclonal antibody against Human Gelsolin (GS). This antibody is labeled with Biotin.

Gelsolin (GS) Monoclonal Antibody (Human), Cy3

4-MAA372Hu22-Cy3
  • EUR 452.40
  • EUR 4470.00
  • EUR 1230.00
  • EUR 582.00
  • EUR 279.60
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Mouse monoclonal antibody against Human Gelsolin (GS). This antibody is labeled with Cy3.

Gelsolin (GS) Monoclonal Antibody (Human), FITC

4-MAA372Hu22-FITC
  • EUR 325.20
  • EUR 2736.00
  • EUR 792.00
  • EUR 403.20
  • EUR 220.80
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Mouse monoclonal antibody against Human Gelsolin (GS). This antibody is labeled with FITC.

Gelsolin (GS) Monoclonal Antibody (Human), HRP

4-MAA372Hu22-HRP
  • EUR 345.60
  • EUR 2958.00
  • EUR 852.00
  • EUR 430.80
  • EUR 234.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Mouse monoclonal antibody against Human Gelsolin (GS). This antibody is labeled with HRP.

Gelsolin (GS) Monoclonal Antibody (Human), PE

4-MAA372Hu22-PE
  • EUR 325.20
  • EUR 2736.00
  • EUR 792.00
  • EUR 403.20
  • EUR 220.80
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Mouse monoclonal antibody against Human Gelsolin (GS). This antibody is labeled with PE.

Gelsolin (GS) Polyclonal Antibody (Bovine), APC

4-PAA372Bo01-APC
  • EUR 435.60
  • EUR 4232.40
  • EUR 1170.00
  • EUR 558.00
  • EUR 271.20
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Bovine Gelsolin (GS). This antibody is labeled with APC.

Gelsolin (GS) Polyclonal Antibody (Bovine), Biotinylated

4-PAA372Bo01-Biotin
  • EUR 388.80
  • EUR 3172.80
  • EUR 927.60
  • EUR 478.80
  • EUR 268.80
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Bovine Gelsolin (GS). This antibody is labeled with Biotin.

Gelsolin (GS) Polyclonal Antibody (Bovine), Cy3

4-PAA372Bo01-Cy3
  • EUR 531.60
  • EUR 5593.20
  • EUR 1510.80
  • EUR 693.60
  • EUR 312.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Bovine Gelsolin (GS). This antibody is labeled with Cy3.

Gelsolin (GS) Polyclonal Antibody (Bovine), FITC

4-PAA372Bo01-FITC
  • EUR 372.00
  • EUR 3409.20
  • EUR 960.00
  • EUR 470.40
  • EUR 241.20
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Bovine Gelsolin (GS). This antibody is labeled with FITC.

Gelsolin (GS) Polyclonal Antibody (Bovine), HRP

4-PAA372Bo01-HRP
  • EUR 397.20
  • EUR 3687.60
  • EUR 1034.40
  • EUR 502.80
  • EUR 255.60
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Bovine Gelsolin (GS). This antibody is labeled with HRP.

Gelsolin (GS) Polyclonal Antibody (Bovine), PE

4-PAA372Bo01-PE
  • EUR 372.00
  • EUR 3409.20
  • EUR 960.00
  • EUR 470.40
  • EUR 241.20
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Bovine Gelsolin (GS). This antibody is labeled with PE.

Gelsolin (GS) Polyclonal Antibody (Human), APC

4-PAA372Hu01-APC
  • EUR 361.20
  • EUR 3174.00
  • EUR 906.00
  • EUR 452.40
  • EUR 240.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Gelsolin (GS). This antibody is labeled with APC.

Gelsolin (GS) Polyclonal Antibody (Human), Biotinylated

4-PAA372Hu01-Biotin
  • EUR 334.80
  • EUR 2397.60
  • EUR 734.40
  • EUR 400.80
  • EUR 246.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Gelsolin (GS). This antibody is labeled with Biotin.

Gelsolin (GS) Polyclonal Antibody (Human), Cy3

4-PAA372Hu01-Cy3
  • EUR 432.00
  • EUR 4182.00
  • EUR 1158.00
  • EUR 553.20
  • EUR 270.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Gelsolin (GS). This antibody is labeled with Cy3.

Gelsolin (GS) Polyclonal Antibody (Human), FITC

4-PAA372Hu01-FITC
  • EUR 313.20
  • EUR 2563.20
  • EUR 748.80
  • EUR 385.20
  • EUR 216.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Gelsolin (GS). This antibody is labeled with FITC.

Gelsolin (GS) Polyclonal Antibody (Human), HRP

4-PAA372Hu01-HRP
  • EUR 332.40
  • EUR 2770.80
  • EUR 805.20
  • EUR 411.60
  • EUR 228.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Gelsolin (GS). This antibody is labeled with HRP.

Gelsolin (GS) Polyclonal Antibody (Human), PE

4-PAA372Hu01-PE
  • EUR 313.20
  • EUR 2563.20
  • EUR 748.80
  • EUR 385.20
  • EUR 216.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Gelsolin (GS). This antibody is labeled with PE.

Gelsolin (GS) Polyclonal Antibody (Human), APC

4-PAA372Hu02-APC
  • EUR 361.20
  • EUR 3174.00
  • EUR 906.00
  • EUR 452.40
  • EUR 240.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Gelsolin (GS). This antibody is labeled with APC.

Gelsolin (GS) Polyclonal Antibody (Human), Biotinylated

4-PAA372Hu02-Biotin
  • EUR 334.80
  • EUR 2397.60
  • EUR 734.40
  • EUR 400.80
  • EUR 246.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Gelsolin (GS). This antibody is labeled with Biotin.

Gelsolin (GS) Polyclonal Antibody (Human), Cy3

4-PAA372Hu02-Cy3
  • EUR 432.00
  • EUR 4182.00
  • EUR 1158.00
  • EUR 553.20
  • EUR 270.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Gelsolin (GS). This antibody is labeled with Cy3.

Gelsolin (GS) Polyclonal Antibody (Human), FITC

4-PAA372Hu02-FITC
  • EUR 313.20
  • EUR 2563.20
  • EUR 748.80
  • EUR 385.20
  • EUR 216.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Gelsolin (GS). This antibody is labeled with FITC.

Gelsolin (GS) Polyclonal Antibody (Human), HRP

4-PAA372Hu02-HRP
  • EUR 332.40
  • EUR 2770.80
  • EUR 805.20
  • EUR 411.60
  • EUR 228.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Gelsolin (GS). This antibody is labeled with HRP.

Gelsolin (GS) Polyclonal Antibody (Human), PE

4-PAA372Hu02-PE
  • EUR 313.20
  • EUR 2563.20
  • EUR 748.80
  • EUR 385.20
  • EUR 216.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Gelsolin (GS). This antibody is labeled with PE.

Gelsolin (GS) Polyclonal Antibody (Human), APC

4-PAA372Hu03-APC
  • EUR 361.20
  • EUR 3174.00
  • EUR 906.00
  • EUR 452.40
  • EUR 240.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Gelsolin (GS). This antibody is labeled with APC.

Gelsolin (GS) Polyclonal Antibody (Human), Biotinylated

4-PAA372Hu03-Biotin
  • EUR 334.80
  • EUR 2397.60
  • EUR 734.40
  • EUR 400.80
  • EUR 246.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Gelsolin (GS). This antibody is labeled with Biotin.

Gelsolin (GS) Polyclonal Antibody (Human), Cy3

4-PAA372Hu03-Cy3
  • EUR 432.00
  • EUR 4182.00
  • EUR 1158.00
  • EUR 553.20
  • EUR 270.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Gelsolin (GS). This antibody is labeled with Cy3.

Gelsolin (GS) Polyclonal Antibody (Human), FITC

4-PAA372Hu03-FITC
  • EUR 313.20
  • EUR 2563.20
  • EUR 748.80
  • EUR 385.20
  • EUR 216.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Gelsolin (GS). This antibody is labeled with FITC.

Gelsolin (GS) Polyclonal Antibody (Human), HRP

4-PAA372Hu03-HRP
  • EUR 332.40
  • EUR 2770.80
  • EUR 805.20
  • EUR 411.60
  • EUR 228.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Gelsolin (GS). This antibody is labeled with HRP.

Gelsolin (GS) Polyclonal Antibody (Human), PE

4-PAA372Hu03-PE
  • EUR 313.20
  • EUR 2563.20
  • EUR 748.80
  • EUR 385.20
  • EUR 216.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Gelsolin (GS). This antibody is labeled with PE.

Gelsolin (GS) Polyclonal Antibody (Human), APC

4-PAA372Hu04-APC
  • EUR 361.20
  • EUR 3174.00
  • EUR 906.00
  • EUR 452.40
  • EUR 240.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Gelsolin (GS). This antibody is labeled with APC.

Gelsolin (GS) Polyclonal Antibody (Human), Biotinylated

4-PAA372Hu04-Biotin
  • EUR 334.80
  • EUR 2397.60
  • EUR 734.40
  • EUR 400.80
  • EUR 246.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Gelsolin (GS). This antibody is labeled with Biotin.

Gelsolin (GS) Polyclonal Antibody (Human), Cy3

4-PAA372Hu04-Cy3
  • EUR 432.00
  • EUR 4182.00
  • EUR 1158.00
  • EUR 553.20
  • EUR 270.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Gelsolin (GS). This antibody is labeled with Cy3.

Gelsolin (GS) Polyclonal Antibody (Human), FITC

4-PAA372Hu04-FITC
  • EUR 313.20
  • EUR 2563.20
  • EUR 748.80
  • EUR 385.20
  • EUR 216.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Gelsolin (GS). This antibody is labeled with FITC.

Gelsolin (GS) Polyclonal Antibody (Human), HRP

4-PAA372Hu04-HRP
  • EUR 332.40
  • EUR 2770.80
  • EUR 805.20
  • EUR 411.60
  • EUR 228.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Gelsolin (GS). This antibody is labeled with HRP.

Gelsolin (GS) Polyclonal Antibody (Human), PE

4-PAA372Hu04-PE
  • EUR 313.20
  • EUR 2563.20
  • EUR 748.80
  • EUR 385.20
  • EUR 216.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Gelsolin (GS). This antibody is labeled with PE.

Gelsolin (GS) Polyclonal Antibody (Human, Mouse)

4-PAA372Mu01
  • EUR 283.20
  • EUR 2805.60
  • EUR 703.20
  • EUR 352.80
  • EUR 250.80
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human, Mouse Gelsolin (GS)

Gelsolin (GS) Polyclonal Antibody (Rat), APC

4-PAA372Ra01-APC
  • EUR 408.00
  • EUR 3843.60
  • EUR 1072.80
  • EUR 518.40
  • EUR 260.40
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Rat Gelsolin (GS). This antibody is labeled with APC.

Gelsolin (GS) Polyclonal Antibody (Rat), Biotinylated

4-PAA372Ra01-Biotin
  • EUR 368.40
  • EUR 2888.40
  • EUR 856.80
  • EUR 450.00
  • EUR 260.40
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Rat Gelsolin (GS). This antibody is labeled with Biotin.

Thermo-Tunable Pores and Antibiotic Gating Properties of Bovine Pores and skin Gelatin Gels Ready with Poly(n-isopropylacrylamide) Community

Polystyrene nanospheres (PNs) had been embedded in bovine pores and skin gelatin gels with a poly(N-isopropylacrylamide) (PNIPAAm) community, which had been denoted as NGHHs, to generate thermoresponsive habits. When 265 nm PNs had been exploited to generate the pores, bovine pores and skin gelatin prolonged to utterly occupy the pores left by PNs beneath the decrease vital answer temperature (LCST), forming a pore-less construction.

Contrarily, above the LCST, the collapse of hydrogen bonding between bovine pores and skin gelatin and PNIPAAm occurred, leading to pores within the NGHH. The habits of pore closing and opening beneath and above the LCST, respectively, signifies the superb drug gating effectivity.

Amoxicillin (AMX) was loaded into the NGHHs as sensible antibiotic gating as a result of pore closing and opening habits. Accordingly, E. coli. and S. aureus had been exploited to check the micro organism inhibition ratio (BIR) of the AMX-loaded NGHHs. BIRs of NGHH with out pores had been 48% to 46.7% at 25 and 37 °C, respectively, for E. coli throughout 12 h of incubation time.

The BIRs of nanoporous NGHH could possibly be enhanced from 61.5% to 90.4% offering a wise antibiotic gate of bovine pores and skin gelatin gels in opposition to irritation from an infection or harm irritation.

Discrimination of extremely degraded, aged Asian and African elephant ivory utilizing denaturing gradient gel electrophoresis (DGGE)

Background: Elephant populations have vastly decreased primarily on account of unlawful poaching for his or her ivory. The commerce in elephant merchandise is protected by nationwide legal guidelines and CITES agreements to stop them from additional decline. For example, in Thailand, it’s unlawful to commerce ivory from African elephants; nonetheless, the legislation permits possession of ivory from Asian elephants if permission has been obtained from the authorities.

As such, technique of enforcement of laws are wanted to categorise the authorized standing of seized ivory merchandise. Many DNA-based methods have been beforehand reported for this function, though all have a restrict of detection not appropriate for very degraded samples.

Intention: We report an assay primarily based on nested PCR adopted by DGGE to substantiate the authorized or unlawful standing of seized ivory samples the place it’s assumed that the DNA can be extremely degraded.

Technique and outcomes: The assay was examined on aged ivory from which the assay was examined for reproducibility, specificity, and, importantly, sensitivity. Blind testing confirmed 100% identification accuracy. Appropriate task in all 304 samples examined was achieved together with affirmation of the authorized standing of 227 extremely degraded, aged ivories, thus underlining the excessive sensitivity of the assay.

Conclusion and suggestion: The analysis output can be helpful to research ivory casework samples in wildlife forensic laboratories.

Results of Emicizumab on APTT, FVIII assays and FVIII Inhibitor assays utilizing completely different reagents: Outcomes of a UK NEQAS proficiency testing train

Introduction: Emicizumab (Hemlibra: Roche Switzerland) is a, humanized, bi-specific monoclonal modified immunoglobulin G4 (IgG4) which binds human FX, FIX and activated FIX (FIXa) to imitate activated FVIII exercise.

Intention: Consider the consequences of emicizumab on the APTT, surrogate FVIII exercise and FVIII inhibitor outcomes.

Strategies: Two samples had been offered, one obtained from an emicizumab handled extreme haemophilia A affected person with FVIII inhibitors and one constructed by in vitro addition of emicizumab utilizing plasma from a extreme haemophilia A affected person with out FVIII inhibitors. An APTT display, surrogate FVIII and FVIII inhibitor assessments had been carried out on each samples by collaborating centres.

Outcomes: APTT outcomes had been beneath the decrease restrict of regular vary. Chromogenic FVIII assay outcomes with the Hyphen/Biophen human component-based assay gave larger than anticipated coefficient of variation (CV) outcomes, 38%-40%. The modified one-stage FVIII assay with emicizumab calibrators confirmed comparable outcomes whatever the APTT reagent. Inhibitor assay median outcomes for pattern S18:23 = 1.43 BU (vary 0.9-3.Zero BU/ml, CV 38%). S18:24 was categorized as beneath the decrease restrict of detection.

Conclusion: APTT screens confirmed a constant shortening. Unmodified one-stage Issue VIII assay outcomes had been remarkably excessive. APTT-based assays are unsuitable for measurement of coagulation components or inhibitors in sufferers handled with emicizumab. Bovine origin chromogenic assays are insensitive to emicizumab and ought to be used to observe FVIII ranges/FVIII inhibitors in emicizumab handled sufferers. Product-specific calibrators ought to be carried out to scale back end result variability.

 

Identification of Immunohistochemical Reagents for In Situ Protein Expression Evaluation of Coronavirus-associated Adjustments in Human Tissues

We studied the suitability of commercially out there monoclonal antibodies (mAbs) for the immunohistochemical (IHC) detection of extreme acute respiratory syndrome coronavirus 2 (SARS-CoV2) in customary archival specimens. Antibodies had been screened on HEK293 cells transfected with viral nucleoprotein, S1 subunit and S2 subunit of spike protein and on untransfected cells, in addition to a panel of regular tissue.

Lung tissue with presence of SARS-CoV2 confirmed by in situ hybridization (ISH) was additionally used. A complete of seven mAbs had been examined: (1) mAb 001 (Sino Organic, 40143-R001), (2) mAb 007 (Sino Organic, 40150-R007), (3) mAb 019 (Sino Organic, 40143-R019), (4) mAb 1A9 (GeneTex, GTX632604), (5) mAb ABM19C9 (Abeomics, 10-10007), (6) FIPV3-70 (Santa Cruz, SC-65653), and (7) mAb 6F10 (BioVision, A2060). Solely 2 mAbs, clone 001 to the nucleoprotein and clone 1A9 to the S2 subunit spike protein displayed particular immunoreactivity.

Each clones confirmed sturdy staining within the acute part of COVID-19 pneumonia, largely in areas of acute diffuse alveolar injury, however weren’t utterly congruent. Viral protein was additionally present in kidney tubules, endothelia of a number of organs and a nasal swab of a affected person with persistent SARS-CoV2 an infection.

GSN Antibody

1-CSB-PA962258
  • EUR 380.40
  • EUR 292.80
  • 100ul
  • 50ul
Description: A polyclonal antibody against GSN. Recognizes GSN from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:1000-1:2000, IHC:1:25-1:100

GSN siRNA

20-abx918793
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

GSN siRNA

20-abx918794
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

GSN Antibody

1-CSB-PA142038
  • EUR 380.40
  • EUR 292.80
  • 100ul
  • 50ul
Description: A polyclonal antibody against GSN. Recognizes GSN from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:5000, IHC:1:50-1:200

GSN Antibody

1-CSB-PA009965GA01HU
  • EUR 716.40
  • EUR 399.60
  • 150ul
  • 50ul
Description: A polyclonal antibody against GSN. Recognizes GSN from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC

GSN Antibody

1-CSB-PA009965HA01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against GSN. Recognizes GSN from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF; Recommended dilution: WB:1:500-1:5000, IHC:1:20-1:200, IF:1:50-1:200

anti-GSN

YF-PA27239 100 ul
EUR 483.6
Description: Rabbit polyclonal to GSN

GSN Antibody

R35137-100UG 100 ug
EUR 399

Automatic CO2 Change Over Unit

INC6176 EACH
EUR 1288.2

Forceps Dissecting Turn Over End

D02129 EACH
EUR 4.67

Bolle TG10 Safety Over Glasses

SAF1106 EACH
EUR 8.39

Gas Change Over Unit 30Psi

GAS1000 EACH
EUR 904.02

Gas Change Over Unit 60Psi

GAS1002 EACH
EUR 905.16

Gas Change Over Unit 100Psi

GAS1004 EACH
EUR 922.26

EP Reagent Biuret Reagent

1011601 1L
EUR 42.18

EP Reagent Iodoplatinate Reagent

1046300 200ML
EUR 360.24

EP Reagent Methoxyphenylacetic Reagent

1053601 100ML
EUR 354.54

EP Reagent Molybdovanadic Reagent

1056700 100ML
EUR 42.18

EP Reagent Phosphomolybdotungstic Reagent

1065000 100ML
EUR 161.88

GSN Rabbit pAb

A2952-100ul 100 ul
EUR 369.6

GSN Rabbit pAb

A2952-200ul 200 ul
EUR 550.8

GSN Rabbit pAb

A2952-20ul 20 ul
EUR 219.6

GSN Rabbit pAb

A2952-50ul 50 ul
EUR 267.6

Gelsolin (GSN) Antibody

20-abx002150
  • EUR 493.20
  • EUR 710.40
  • EUR 218.40
  • EUR 376.80
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul

Gelsolin (GSN) Antibody

20-abx002844
  • EUR 493.20
  • EUR 710.40
  • 100 ul
  • 200 ul

Gelsolin (GSN) Antibody

20-abx112696
  • EUR 878.40
  • EUR 477.60
  • 150 ul
  • 50 ul

Gelsolin (GSN) Antibody

abx025301-100ul 100 ul
EUR 627.6

Gelsolin (GSN) Antibody

abx025302-400ul 400 ul
EUR 627.6

Gelsolin (GSN) Antibody

abx025302-80l 80 µl
EUR 343.2

GSN Rabbit pAb

A16869-100ul 100 ul
EUR 369.6

GSN Rabbit pAb

A16869-200ul 200 ul
EUR 550.8

GSN Rabbit pAb

A16869-20ul 20 ul
EUR 219.6

GSN Rabbit pAb

A16869-50ul 50 ul
EUR 267.6

GSN Rabbit pAb

A3903-100ul 100 ul
EUR 369.6

GSN Rabbit pAb

A3903-200ul 200 ul
EUR 550.8

GSN Rabbit pAb

A3903-20ul 20 ul Ask for price

GSN Rabbit pAb

A3903-50ul 50 ul Ask for price

Gelsolin (GSN) Antibody

20-abx225202
  • EUR 444.00
  • EUR 727.20
  • EUR 376.80
  • 100 ul
  • 200 ul
  • 50 ul

Gelsolin (GSN) Antibody

20-abx241662
  • EUR 493.20
  • EUR 360.00
  • 100 ul
  • 50 ul

Gelsolin (GSN) Antibody

20-abx302716
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Gelsolin (GSN) Antibody

abx430833-200ul 200 ul
EUR 460.8

Gelsolin (GSN) Antibody

abx233417-100ug 100 ug
EUR 577.2

Gelsolin (GSN) Antibody

20-abx213864
  • EUR 493.20
  • EUR 360.00
  • 100 ul
  • 50 ul

Gelsolin (GSN) Antibody

20-abx215741
  • EUR 510.00
  • EUR 410.40
  • 100 ug
  • 50 ug

GSN Blocking Peptide

DF7117-BP 1mg
EUR 234

GSN Conjugated Antibody

C31204 100ul
EUR 476.4

GSN Conjugated Antibody

C38506 100ul
EUR 476.4

Anti-GSN antibody

STJ119230 100 µl
EUR 332.4
Description: The protein encoded by this gene binds to the "plus" ends of actin monomers and filaments to prevent monomer exchange. The encoded calcium-regulated protein functions in both assembly and disassembly of actin filaments. Defects in this gene are a cause of familial amyloidosis Finnish type (FAF). Multiple transcript variants encoding several different isoforms have been found for this gene.

Anti-GSN antibody

STJ23881 100 µl
EUR 332.4
Description: The protein encoded by this gene binds to the 'plus' ends of actin monomers and filaments to prevent monomer exchange. The encoded calcium-regulated protein functions in both assembly and disassembly of actin filaments. Defects in this gene are a cause of familial amyloidosis Finnish type (FAF). Multiple transcript variants encoding several different isoforms have been found for this gene.

Anti-GSN antibody

STJ23882 100 µl
EUR 332.4
Description: The protein encoded by this gene binds to the 'plus' ends of actin monomers and filaments to prevent monomer exchange. The encoded calcium-regulated protein functions in both assembly and disassembly of actin filaments. Defects in this gene are a cause of familial amyloidosis Finnish type (FAF). Multiple transcript variants encoding several different isoforms have been found for this gene.

pOTB7-GSN Plasmid

PVTB00880-2a 2 ug
EUR 427.2

GSN Polyclonal Antibody

A70501-050 50 ul
EUR 302.5

GSN Polyclonal Antibody

A70501-100 100 ul
EUR 423.5

GSN Polyclonal Antibody

A50273-020 20 ul Ask for price

GSN Polyclonal Antibody

A50273-050 50 ul Ask for price

GSN Polyclonal Antibody

A50273-100 100 ul
EUR 423.5

GSN Polyclonal Antibody

A50273
  • EUR 684.66
  • Ask for price
  • Ask for price
  • EUR 423.50
  • 100 µg
  • 20 ul
  • 50 ul
  • 100 ul

GSN Polyclonal Antibody

A70501
  • EUR 302.50
  • EUR 423.50
  • 50 ul
  • 100 ul

GSN Antibody / Gelsolin

F54920-0.08ML 0.08 ml
EUR 165

GSN Antibody / Gelsolin

F54920-0.4ML 0.4 ml
EUR 379

GSN Antibody / Gelsolin

RQ5138 100ul
EUR 419

GSN Antibody / Gelsolin

V7827-100UG 100 ug
EUR 499
Description: Gelsolin (also known as brevin, Actin-depolymerizing factor or ADF), a proteinof leukocytes, platelets and other cells, severs Actin filaments in thepresence of submicromolar calcium, thereby isolating cytoplasmic Actin gels. It is a calcium-regulated, actin-modulating protein that binds to the plus (or barbed) ends of actin monomers or filaments, preventing monomer exchange (end-blocking or capping). It can promote the assembly of monomers into filaments (nucleation) as well as sever filaments already formed. Plays a role in ciliogenesis. Defects in GSN are the cause of amyloidosis type 5 (AMYL5); also known as familial amyloidosis Finnish type, typically characterized by cranial neuropathy and lattice corneal dystrophy. Severe systemic disease can develop in some individuals causing peripheral polyneuropathy, amyloid cardiomyopathy, and nephrotic syndrome leading to renal failure.

GSN Antibody / Gelsolin

V7827-20UG 20 ug
EUR 219
Description: Gelsolin (also known as brevin, Actin-depolymerizing factor or ADF), a proteinof leukocytes, platelets and other cells, severs Actin filaments in thepresence of submicromolar calcium, thereby isolating cytoplasmic Actin gels. It is a calcium-regulated, actin-modulating protein that binds to the plus (or barbed) ends of actin monomers or filaments, preventing monomer exchange (end-blocking or capping). It can promote the assembly of monomers into filaments (nucleation) as well as sever filaments already formed. Plays a role in ciliogenesis. Defects in GSN are the cause of amyloidosis type 5 (AMYL5); also known as familial amyloidosis Finnish type, typically characterized by cranial neuropathy and lattice corneal dystrophy. Severe systemic disease can develop in some individuals causing peripheral polyneuropathy, amyloid cardiomyopathy, and nephrotic syndrome leading to renal failure.

GSN Antibody / Gelsolin

V7827SAF-100UG 100 ug
EUR 499
Description: Gelsolin (also known as brevin, Actin-depolymerizing factor or ADF), a proteinof leukocytes, platelets and other cells, severs Actin filaments in thepresence of submicromolar calcium, thereby isolating cytoplasmic Actin gels. It is a calcium-regulated, actin-modulating protein that binds to the plus (or barbed) ends of actin monomers or filaments, preventing monomer exchange (end-blocking or capping). It can promote the assembly of monomers into filaments (nucleation) as well as sever filaments already formed. Plays a role in ciliogenesis. Defects in GSN are the cause of amyloidosis type 5 (AMYL5); also known as familial amyloidosis Finnish type, typically characterized by cranial neuropathy and lattice corneal dystrophy. Severe systemic disease can develop in some individuals causing peripheral polyneuropathy, amyloid cardiomyopathy, and nephrotic syndrome leading to renal failure.

DURAN Over-Cap 45mm Black Phenolic

BOT2596 PK10
EUR 25.08

EP Reagent Sulfomolybdic Reagent R3

1086500 1L
EUR 287.28

BOP reagent

5-02141 25g Ask for price

BOP reagent

5-02142 100g Ask for price

Chymase reagent

30C-CP1129 5 units
EUR 2622
Description: Purified native Human Chymase reagent

BOP reagent

A7015-100000 100 g
EUR 240
Description: A peptide coupling reagent. Can be used in the preparation of phenyl esters of amino acids which have been shown to be valuable as blocked derivatives of amino acids in the field of peptide synthesis.

BOP reagent

A7015-25000 25 g
EUR 135.6
Description: A peptide coupling reagent. Can be used in the preparation of phenyl esters of amino acids which have been shown to be valuable as blocked derivatives of amino acids in the field of peptide synthesis.

Bradford reagent

BDE641 100ml
EUR 73.21

Bluing Reagent

BRT030 30 ml
EUR 72

Bluing Reagent

BRT125 125 ml
EUR 75.6

Bluing Reagent

BRT3800 1 Gal.
EUR 220.8

Bluing Reagent

BRT500 500 ml
EUR 91.2

Bluing Reagent

BRT999 1000 ml
EUR 105.6

Beaucage reagent

HY-100951 10mM/1mL
EUR 151.2

Phosphate Reagent

106199 PK100
EUR 61.29

Chromium Reagent

1206699 EACH
EUR 141.72

Ninhydrin Reagent

MIC6746 EACH
EUR 31.12

Nessler Reagent

NESSR 500ML
EUR 148.2

Thioacetamide Reagent

THIOR01 100ML
EUR 78.66

Traut's Reagent

2330-1000 each
EUR 418.8

Traut's Reagent

2330-500 each
EUR 248.4

MTS Reagent

2808-1000 each
EUR 1188

MTS Reagent

2808-250 each
EUR 438

MTT Reagent

2809-1G each
EUR 216

MTT Reagent

2809-5G each
EUR 652.8

BURGESS REAGENT

702010 each Ask for price

Gelsolin (GSN) Antibody (HRP)

20-abx304087
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Gelsolin (GSN) Antibody (FITC)

20-abx304088
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Gelsolin (GSN) Antibody (Biotin)

20-abx304089
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Cow Gelsolin (GSN) Protein

abx670126-20ug 20 ug
EUR 727.2

Human GSN shRNA Plasmid

20-abx951982
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

Mouse GSN shRNA Plasmid

20-abx981597
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

Rat GSN shRNA Plasmid

20-abx988824
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

GSN Antibody, HRP conjugated

1-CSB-PA009965HB01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against GSN. Recognizes GSN from Human. This antibody is HRP conjugated. Tested in the following application: ELISA

GSN Antibody, FITC conjugated

1-CSB-PA009965HC01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against GSN. Recognizes GSN from Human. This antibody is FITC conjugated. Tested in the following application: ELISA

GSN Antibody, Biotin conjugated

1-CSB-PA009965HD01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against GSN. Recognizes GSN from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA

GSN ELISA KIT|Human

EF000590 96 Tests
EUR 826.8

Human GSN ELISA Kit

ELA-E0372h 96 Tests
EUR 988.8

Anti-Gelsolin/GSN Antibody

PA2109 100ug/vial
EUR 400.8

Anti-Gelsolin/GSN Antibody

PB9209 100ug/vial
EUR 400.8

Anti-Gelsolin / GSN antibody

STJ71038 100 µg
EUR 430.8

GSN Recombinant Protein (Rat)

RP203813 100 ug Ask for price

GSN Recombinant Protein (Human)

RP061368 100 ug Ask for price

GSN Recombinant Protein (Mouse)

RP140204 100 ug Ask for price

GSN Recombinant Protein (Mouse)

RP140207 100 ug Ask for price

GSN Recombinant Protein (Mouse)

RP140210 100 ug Ask for price

GSN Recombinant Protein (Mouse)

RP140213 100 ug Ask for price

HEK-293T Telomerase Over-Expressing Cell Pellet

abx069991-1Pellet 1 Pellet
EUR 477.6

Visitor Eye Shield Over Specs - Portwest PW30

SAF1021 EACH
EUR 3.42

Esophagus Lysate

1365 0.1 mg
EUR 229.2
Description: Esophagus tissue lysate was prepared by homogenization in lysis buffer (10 mM HEPES pH7.9, 1.5 mM MgCl2, 10 mM KCl, 1 mM ethylenediaminetetraacetic acid, 10% glycerol, 1% NP-40, and a cocktail of protease inhibitors). Tissue and cell debris was removed by centrifugation. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT.

Ileum Lysate

1367 0.1 mg
EUR 229.2
Description: Ileum tissue lysate was prepared by homogenization in lysis buffer (10 mM HEPES pH7.9, 1.5 mM MgCl2, 10 mM KCl, 1 mM ethylenediaminetetraacetic acid, 10% glycerol, 1% NP-40, and a cocktail of protease inhibitors). Tissue and cell debris was removed by centrifugation. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT.

Rectum Lysate

1373 0.1 mg
EUR 229.2
Description: Rectum tissue lysate was prepared by homogenization in homogenization in lysis buffer (10 mM HEPES pH7.9, 1.5 mM MgCl2, 10 mM KCl, 1 mM ethylenediaminetetraacetic acid, 10% glycerol, 1% NP-40, and a cocktail of protease inhibitors). Tissue and cell debris was removed by centrifugation. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT.

Skin Lysate

1376 0.1 mg
EUR 229.2
Description: Skin tissue lysate was prepared by homogenization in lysis buffer (10 mM HEPES pH7.9, 1.5 mM MgCl2, 10 mM KCl, 1 mM ethylenediaminetetraacetic acid, 10% glycerol, 1% NP-40, and a cocktail of protease inhibitors). Tissue and cell debris was removed by centrifugation. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT.

Thyroid Lysate

1380 0.1 mg
EUR 229.2
Description: Thyroid tissue lysate was prepared by homogenization in lysis buffer (10 mM HEPES pH7.9, 1.5 mM MgCl2, 10 mM KCl, 1 mM ethylenediaminetetraacetic acid, 10% glycerol, 1% NP-40, and a cocktail of protease inhibitors). Tissue and cell debris was removed by centrifugation. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT.

Spleen Lysate

1406 0.1 mg
EUR 229.2
Description: Spleen tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT.

Bladder Lysate

1410 0.1 mg
EUR 229.2
Description: Bladder tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT.

Cerebellum Lysate

1412 0.1 mg
EUR 229.2
Description: Cerebellum tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT.

Cerebrum Lysate

1413 0.1 mg
EUR 229.2
Description: Cerebrum tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT.

Pancreas Lysate

1414 0.1 mg
EUR 229.2
Description: Pancreas tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT.

Stomach Lysate

1415 0.1 mg
EUR 229.2
Description: Stomach tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT.

Testis Lysate

1416 0.1 mg
EUR 229.2
Description: Testis tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT.

Adrenal Lysate

1417 0.1 mg
EUR 229.2
Description: Adrenal tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT.

Skin Lysate

1419 0.1 mg
EUR 229.2
Description: Skin tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT.

Eye Lysate

1420 0.1 mg
EUR 229.2
Description: Eye tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT.

Trachea Lysate

1422 0.1 mg
EUR 229.2
Description: Trachea tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT.

Lung Lysate

1462 0.1 mg
EUR 229.2
Description: Lung tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT.

Liver Lysate

1464 0.1 mg
EUR 229.2
Description: Liver tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT.

Kidney Lysate

1465 0.1 mg
EUR 229.2
Description: Kidney tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT.

Spleen Lysate

1466 0.1 mg
EUR 229.2
Description: Spleen tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT.

L1210 Lysate

1284 0.1 mg
EUR 229.2
Description: L1210 lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The L1210 lysate was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT.

C2C12 Lysate

1285 0.1 mg
EUR 229.2
Description: C2C12 lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The C2C12 lysate was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT.

P815 Lysate

1286 0.1 mg
EUR 229.2
Description: P815 lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The P815 lysate was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT.

EL4 Lysate

1287 0.1 mg
EUR 229.2
Description: EL4 lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The EL4 lysate was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT.

Lung Lysate

1302 0.1 mg
EUR 229.2
Description: Lung tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT.

Spleen Lysate

1306 0.1 mg
EUR 229.2
Description: Spleen tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT.

Placenta Lysate

1309 0.1 mg
EUR 229.2
Description: Placenta tissue lysate was prepared by homogenization in lysis buffer (10 mM HEPES pH7.9, 1.5 mM MgCl2, 10 mM KCl, 1 mM ethylenediaminetetraacetic acid, 10% glycerol, 1% NP-40, and a cocktail of protease inhibitors). Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT.

Jurkat Lysate

1205 0.1 mg
EUR 229.2
Description: Jurkat lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The Jurkat lysate was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT.

MOLT4 Lysate

1206 0.1 mg
EUR 229.2
Description: MOLT4 lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The MOLT4 lysate was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT.

HL60 Lysate

1209 0.1 mg
EUR 229.2
Description: HL60 lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The HL60 lysate was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT.

T24 Lysate

1213 0.1 mg
EUR 229.2
Description: T24 lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The T24 lysate was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT.

U937 Lysate

1215 0.1 mg
EUR 229.2
Description: U937 lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The U937 lysate was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT.

MCF7 Lysate

1219 0.1 mg
EUR 229.2
Description: MCF7 lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The MCF7 lysate was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT.

Ramos Lysate

1225 0.1 mg
EUR 229.2
Description: Ramos lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The Ramos lysate was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT.

Kidney Lysate

21-104 0.1 mg
EUR 342.6
Description: Bovine kidney tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The bovine kidney tissue total protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the kidney tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The kidney tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot.

Liver Lysate

21-105 0.1 mg
EUR 342.6
Description: Bovine liver tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The bovine liver tissue total protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the liver tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The liver tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot.

Heart Lysate

21-115 0.1 mg
EUR 342.6
Description: Guinea Pig heart tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The guinea pig heart tissue total protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the heart tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The heart tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot.

Kidney Lysate

21-116 0.1 mg
EUR 342.6
Description: Guinea Pig kidney tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The guinea pig kidney tissue total protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the kidney tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The kidney tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot.

Adrenal Lysate

21-160 0.1 mg
EUR 468.6
Description: Monkey (Cynomolgus) adrenal tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The monkey (Cynomolgus) adrenal tissue total protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the adrenal tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The adrenal tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot.

Colon Lysate

21-179 0.1 mg
EUR 342.6
Description: Monkey (Cynomolgus) colon tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The monkey (Cynomolgus) colon tissue total protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the colon tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The colon tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot.

Gallbladder Lysate

21-188 0.1 mg
EUR 468.6
Description: Monkey (Cynomolgus) gallbladder tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The monkey (Cynomolgus) gallbladder tissue total protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the gallbladder tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The gallbladder tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot.

Kidney Lysate

21-190 0.1 mg
EUR 342.6
Description: Monkey (Cynomolgus) kidney tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The monkey (Cynomolgus) kidney tissue total protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the kidney tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The kidney tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot.

Lung Lysate

21-194 0.1 mg
EUR 342.6
Description: Monkey (Cynomolgus) lung tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The monkey (Cynomolgus) lung tissue total protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the lung tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The lung tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot.

Skin Lysate

21-204 0.1 mg
EUR 468.6
Description: Monkey (Cynomolgus) skin tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The monkey (Cynomolgus) skin tissue total protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the skin tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The skin tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot.

Spleen Lysate

21-209 0.1 mg
EUR 342.6
Description: Monkey (Cynomolgus) spleen tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The monkey (Cynomolgus) spleen tissue total protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the spleen tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The spleen tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot.

Brain Lysate

21-272 0.1 mg
EUR 342.6
Description: Monkey (Rhesus) brain tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The monkey (Rhesus) brain tissue total protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the brain tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The brain tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot.

Colon Lysate

21-288 0.1 mg
EUR 342.6
Description: Monkey (Rhesus) colon tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The monkey (Rhesus) colon tissue total protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the colon tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The colon tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot.

Leave a Reply

Your email address will not be published. Required fields are marked *